EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma

EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma

Abstract Background Ephrin receptors (Eph) and their ligands, called ephrins, function in various disease processes. However, the expression level and prognostic value of Eph/ephrins in lung adenocarcinoma (LUAD) are still unclear. Methods The Oncomine and GEPIA databases were used to explore the di...

Full description

Bibliographic Details
Main Authors: Mingming Deng, Run Tong, Zhe Zhang, Tao Wang, Chaonan Liang, Xiaoming Zhou, Gang Hou
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Cancer Cell International
Subjects:
EFNA3
Lung cancer
Prognosis
Biomarker
Immunotherapy response
Online Access:https://doi.org/10.1186/s12935-021-02226-x

Internet

https://doi.org/10.1186/s12935-021-02226-x

Similar Items